Literature DB >> 16517210

A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy.

Fumio Hidaka1, Susumu Matsuo, Tatsushi Muta, Koichiro Takeshige, Tomoyuki Mizukami, Hiroyuki Nunoi.   

Abstract

Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns and mediate the activation of NF-kappaB and the production of proinflammatory cytokines, which is critical for the innate immune system. TLR3 recognizes both double-stranded RNA and the influenza A virus. Since influenza-associated encephalopathy is frequent in Japan and East Asia and its pathological mechanism remains unknown, we analyzed several genes including TLRs and the retinoic acid inducible gene I, which could be involved in the recognition of the RNA virus. In one of three patients with influenza-associated encephalopathy, we detected a novel missense mutation (F303S) in just the TLR3 gene. This was confirmed as a loss-of-function mutant in a dose-dependent manner by NF-kappaB and IFN-beta reporter assays using wild-type and mutant TLR3-transfected HEK293 cells. Our results imply that a mutation of the TLR3 gene could be one of the factors responsible for influenza-associated encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517210     DOI: 10.1016/j.clim.2006.01.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  46 in total

Review 1.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

2.  A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.

Authors:  Hideo Negishi; Tomoko Osawa; Kentaro Ogami; Xinshou Ouyang; Shinya Sakaguchi; Ryuji Koshiba; Hideyuki Yanai; Yoshinori Seko; Hiroshi Shitara; Keith Bishop; Hiromichi Yonekawa; Tomohiko Tamura; Tsuneyasu Kaisho; Choji Taya; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

3.  Characterization of equine and other vertebrate TLR3, TLR7, and TLR8 genes.

Authors:  Natalia M Astakhova; Andrey A Perelygin; Andrey A Zharkikh; Teri L Lear; Stephen J Coleman; James N MacLeod; Margo A Brinton
Journal:  Immunogenetics       Date:  2009-07-01       Impact factor: 2.846

Review 4.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

Review 5.  Toll-like receptors: key players in antiviral immunity.

Authors:  Nicholas Arpaia; Gregory M Barton
Journal:  Curr Opin Virol       Date:  2011-10-28       Impact factor: 7.090

Review 6.  Evasion of innate and adaptive immune responses by influenza A virus.

Authors:  Mirco Schmolke; Adolfo García-Sastre
Journal:  Cell Microbiol       Date:  2010-05-06       Impact factor: 3.715

7.  Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.

Authors:  Stephan A Grupp; Eline Luning Prak; Jean Boyer; Kenyetta R McDonald; Suzanne Shusterman; Edward Thompson; Colleen Callahan; Abbas F Jawad; Bruce L Levine; Carl H June; Kathleen E Sullivan
Journal:  Clin Cancer Res       Date:  2012-10-23       Impact factor: 12.531

Review 8.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Immune dysregulation in severe influenza.

Authors:  Meredith L Heltzer; Susan E Coffin; Kelly Maurer; Asen Bagashev; Zhe Zhang; Jordan S Orange; Kathleen E Sullivan
Journal:  J Leukoc Biol       Date:  2009-06       Impact factor: 4.962

10.  Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3.

Authors:  Jeannine A Majde; Levente Kapás; Stewart G Bohnet; Alok De; James M Krueger
Journal:  Brain Behav Immun       Date:  2009-10-25       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.